ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Nicox SA

Nicox SA (ALCOX)

0.304
0.002
(0.66%)
Closed February 07 10:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.304
Bid
0.296
Ask
0.304
Volume
155,673
0.296 Day's Range 0.31
0.14 52 Week Range 0.4915
Market Cap
Previous Close
0.302
Open
0.31
Last Trade
100
@
0.304
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
142,451
Shares Outstanding
50,299,694
Dividend Yield
-
PE Ratio
-13.66
Earnings Per Share (EPS)
-0.42
Revenue
7.14M
Net Profit
-20.88M

About Nicox SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Antibes, Alpes-maritimes, Fra
Founded
-
Nicox SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCOX. The last closing price for Nicox was 0.30 €. Over the last year, Nicox shares have traded in a share price range of 0.14 € to 0.4915 €.

Nicox currently has 50,299,694 shares outstanding. The market capitalization of Nicox is 15.19 € million. Nicox has a price to earnings ratio (PE ratio) of -13.66.

ALCOX Latest News

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025

Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Press Release Nicox Announces Scientific Presentation and Conference Attendance in H1 2025January 28, 2025 – release at...

Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025

Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Communiqué de presseNicox : Présentation Scientifique et Participation aux Congrès du premier semestre...

Nicox confirme son éligibilité au PEA-PME

Nicox confirme son éligibilité au PEA-PME Communiqué de presseNicox confirme son éligibilité au PEA-PME22 janvier 2025 – publication à 7H30Sophia Antipolis, FranceNicox SA (Euronext Growth Paris :...

Nicox : Point d’activité et résumé financier du quatrième trimestre 2024

Nicox : Point d’activité et résumé financier du quatrième trimestre 2024 Communiqué de presseNicox : Point d’activité et résumé financier du quatrième trimestre 2024  Recrutement du dernier...

Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights

Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Press Release Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Last patient recruited in the...

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents

Nicox annonce la première vente commerciale de ZERVIATE en Chine par son partenaire Ocumension, création d’une nouvelle source de revenus récurrents Communiqué de presseNicox annonce la première...

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream

Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream Press Release Nicox Announces First Commercial Sale of ZERVIATE in China...

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.003-0.9771986970680.3070.310.291573990.30014254DE
4-0.017-5.295950155760.3210.3260.2905804700.30470362DE
120.06426.66666666670.240.3350.20051424510.2855273DE
260.134679.45690672960.16940.3350.142457790.26233817DE
52-0.101-24.93827160490.4050.49150.141742510.26458174DE
156-0.278-47.76632302410.5820.650.141353840.31745213DE
260-0.278-47.76632302410.5820.650.141353840.31745213DE

ALCOX - Frequently Asked Questions (FAQ)

What is the current Nicox share price?
The current share price of Nicox is 0.304 €
How many Nicox shares are in issue?
Nicox has 50,299,694 shares in issue
What is the market cap of Nicox?
The market capitalisation of Nicox is EUR 15.19M
What is the 1 year trading range for Nicox share price?
Nicox has traded in the range of 0.14 € to 0.4915 € during the past year
What is the PE ratio of Nicox?
The price to earnings ratio of Nicox is -13.66
What is the cash to sales ratio of Nicox?
The cash to sales ratio of Nicox is 39.93
What is the reporting currency for Nicox?
Nicox reports financial results in EUR
What is the latest annual turnover for Nicox?
The latest annual turnover of Nicox is EUR 7.14M
What is the latest annual profit for Nicox?
The latest annual profit of Nicox is EUR -20.88M
What is the registered address of Nicox?
The registered address for Nicox is SUNDESK SOPHIA ANTIPOLIS ,EMERALD SQUARE, B��TIMENT C, RUE EVARISTE GALOIS, BIOT, ANTIBES, ALPES-MARITIMES, 06410
What is the Nicox website address?
The website address for Nicox is www.nicox.com
Which industry sector does Nicox operate in?
Nicox operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCABCabasse SA
0.77 €
(67.39%)
93.29k
ALEXPOne Experience
0.496 €
(64.24%)
2.54k
VTRVitura
5.80 €
(62.92%)
2.37k
DMSBSDiagnostic Medical Systems
0.007 €
(40.00%)
15.1k
ALVERVergnet
0.0009 €
(28.57%)
23.09M
ALCYBCybergun
0.0001 €
(-50.00%)
18.59M
BAIOdyssey Acquisition SA
0.1285 €
(-49.80%)
834.05k
ALALOAcheterLouerFR
0.0148 €
(-34.80%)
2.31M
MLWEYWeya
0.018 €
(-33.33%)
52.31k
MLCOTCoretech 5
0.0335 €
(-33.00%)
61k
ATOAtos SE
0.0021 €
(0.00%)
1.12B
ALVERVergnet
0.0009 €
(28.57%)
23.09M
ALCYBCybergun
0.0001 €
(-50.00%)
18.59M
ALHGLouis Hachette Group
1.331 €
(-2.90%)
11.49M
BCPBanco Comercial Portugues SA
0.5008 €
(-1.14%)
10.67M

Discussion

View Full Feed
gorbec1 gorbec1 34 seconds ago
Got me beat I’m still doing this till this today lol
MCIC
4u2nv2 4u2nv2 53 seconds ago
I am sorry. This is not where I should be. I am looking for $MCIC Pushers anonymous $$. I feel so bad. I push people at the subway stations and at the tops of stairs. I don't mean anything by it but it seems to create problems. I remember a few mountain hiking trails and I just could not help myself
MCIC
Wingsjr Wingsjr 2 minutes ago
Tax policy will be done in the next few months and Pulte won’t be confirmed until June. Relist is what all of us should be posting and email to Bessent, 45-47, DOGE and all platforms.
FNMA
Golden Cross Golden Cross 3 minutes ago
When this one takes off it will make people rich..........$TORVF
TORVF
MartinLutherKing MartinLutherKing 3 minutes ago
Nobel prize micro Rna breakthrough at the highest level of research
No safety concerns or dose limiting toxicities reported across all nine patients
TTX-MC138 achieved 66% inhibition of miR-10b at 24 hours post-infusion
Successful dose escalation with increased activity in Coh
RNAZ
Hi_Lo Hi_Lo 3 minutes ago
So why has Sharp done nothing in three years?
Because for the past more than two years he was in a court battle with Calasse. That's why.

But that's all over now.

Now Sharp has to deliver here with a merger to save the little credibility he has left.
WNFT
JTORENCE JTORENCE 3 minutes ago
starric What is this all about. Don't understand the point you are trying to get across. Not gonna waste my time . You posted the link so now explain it.
NWBO
Bill48 Bill48 4 minutes ago
I don’t think you’ve been proven wrong either! Your research is not flawed in any way but straight forward! Thanks for sharing your thoughts and opinions here! I take them seriously! Thanks again!!
COOP
Nebraskan Nebraskan 4 minutes ago
https://www.sec.gov/cgi-bin/browse-edgar?company=nioCorp&owner=exclude&action=getcompany
NB
MrMike241 MrMike241 5 minutes ago
That was good, rational, logical. The Lincoln Project does good work!
Nerdy1 Nerdy1 6 minutes ago
New White House website contact form. I was watching the recent press briefing at the White House and they talked about the new website. I have written my concerns a couple of times now. Hopefully they act soon and end this madness.
https://www.whitehouse.gov/contact/
FNMA
Truth and Transparency Truth and Transparency 7 minutes ago
You crack me up. Love how you only post the common shares. Why don’t you post the Fully Diluted Shares Outstanding! Nebraskan, you are a full on fraud.

https://www.niocorp.com/investor-center/share-structure/
NB
B402 B402 9 minutes ago
John has that nack of speaking truth to power....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175778679

I did. Though I'm not sure what he's up to now
3331 3331 9 minutes ago
BIEL: HUGE - EFFECTIVE FOR CARPAL TUNNEL PAIN!!!

https://medicinskiglasnik.ba/article/2030

Results All patients showed an improvement in pain level and functional capacity after using ActiPatch for pillar pain management. Additionally, none of the patients experienced p
michael702/ michael702/ 9 minutes ago
I word things wrong
BLLB
4u2nv2 4u2nv2 9 minutes ago
Give me a little break. It was my first dang stock. Yea. I did better later down the road.
MCIC
michael702/ michael702/ 9 minutes ago
I usually get thrown off anything I get on for some reason they don't like old people I guess
BLLB
kenjiroo kenjiroo 9 minutes ago
EM again in April !! No doubt
TPTW
quester614 quester614 10 minutes ago
Did you see the pic of Trump when he signed the Riley Gaines Act. He had all those little girls around him and didn't sniff one head. LOLOLOLOL
XERI
3331 3331 10 minutes ago
BIEL: HUGE - EFFECTIVE FOR CARPAL TUNNEL PAIN!!!

https://medicinskiglasnik.ba/article/2030

Results All patients showed an improvement in pain level and functional capacity after using ActiPatch for pillar pain management. Additionally, none of the patients experienced p
michael702/ michael702/ 11 minutes ago
I'm not on Instagram that I know of anyway
BLLB
Brysh Brysh 12 minutes ago
Annual report filed https://www.otcmarkets.com/otcapi/company/financial-report/421639/content
IDVV
janice shell janice shell 13 minutes ago
Annnnnddd we return to there newly faddish "common sense", which Trumpty and his followers hope someone will mistake for critical thinking.
gorbec1 gorbec1 13 minutes ago
I feel your pain some of us just don’t know how to trade lol
MCIC

Your Recent History

Delayed Upgrade Clock